What this study is
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
What's being tested
- GORE® TAG® Thoracic Branch Endoprosthesis
Intervention · DEVICE
Lesions in aortic arch in Zone 0 or Zone 1
Study details
- Sponsor
- W.L.Gore & Associates
- Conditions
- Aortic Arch Dissection · Aortic Arch Aneurysm
- Enrolling
- 125 people
- Starts
- 2026-03-02
- Est. completion
- 2036-03
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements.
- Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1.
- Patient is age ≥ 18 years at time of informed consent signature.
You can't join if
- Patient who is, at the time of consent, unlikely to be available for defined follow-up visits.
- Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study within 12 months of study enrollment. Subjects cannot be enrolled in another Gore study.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (24)
24 openHonorHealth
Scottsdale, Arizona, United States
- Hasan Aldailami, MD · Contact480-246-3000haldailami@honorhealth.com
- Hasan Aldailami, MD · Principal investigator
RecruitingKeck Medical Center of USC
Los Angeles, California, United States
- Sukgu Han, MD · Contact323-442-5849sukgu.han@med.usc.edu
- Sukgu Han, MD · Principal investigator
RecruitingStanford University Hospital and Clinics
Palo Alto, California, United States
- A. Claire Watkins, MD · Contact650-723-5771acwat@stanford.edu
- A. Claire Watkins, MD · Principal investigator
RecruitingUniversity of California Davis Health System
Sacramento, California, United States
- Andrew Barleben, MD · Contact916-734-6609abarleben@health.ucdavis.edu
- Andrew Barleben, MD · Principal investigator
RecruitingSanta Barbara Cottage Research Institute
Santa Barbara, California, United States
- Michael Paisley, MD · Contact805-456-8890mpaisley@sbvascularspecialists.com
- Michael Paisley, MD · Principal investigator
RecruitingHartford Hospital
Hartford, Connecticut, United States
- Akhilesh Jain, MD · Contact860-522-4158akhilesh.jain@hhchealth.org
- Akhilesh Jain, MD · Principal investigator
RecruitingMedStar Washington Hospital Center
Washington D.C., District of Columbia, United States
- William Yoon, MD · Contact202-877-5975william.j.yoon@medstar.net
- William Yoon, MD · Principal investigator
RecruitingUniversity of Florida Health Heart & Vascular
Gainesville, Florida, United States
- Martin Back, MD · Contact352-273-5484martin.back@surgery.ufl.edu
- Martin Back, MD · Principal investigator
RecruitingLakeland Regional Medical Center
Lakeland, Florida, United States
- Mohammed Hassan, MD · Contact863-413-5969mohammed.hassan@mylrh.org
- Mohammed Hassan, MD · Principal investigator
RecruitingUniversity of South Florida
Tampa, Florida, United States
- Halim Yammine, MD · Contact813-821-8034hyammine@usf.edu
- Halim Yammine, MD · Principal investigator
RecruitingUniversity of Maryland School of Medicine
Baltimore, Maryland, United States
- Shahab Toursavadkohi, MD · Contact410-328-5840stoursavadkohi@som.umaryland.edu
- Shahab Toursavadkohi, MD · Principal investigator
RecruitingJohns Hopkins University
Baltimore, Maryland, United States
- Mehrdad Ghoreishi, MD · Contact410-955-2800mghorei1@jh.edu
- Mehrdad Ghoreishi, MD · Principal investigator
RecruitingMassachusetts General Hospital
Boston, Massachusetts, United States
- Jahan Mohebali, MD · Contact617-726-8875mohebali.jahan@mgh.harvard.edu
- Jahan Mohebali, MD · Principal investigator
RecruitingUniversity of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Mark Farber, MD · Contact919-966-3391mark_farber@med.unc.edu
- Mark Faber, MD · Principal investigator
RecruitingDuke University Medical Center
Durham, North Carolina, United States
- G. Chad Hughes IV, MD · Contact919-668-0903gchad.hughes@duke.edu
- G. Chad Hughes IV, MD · Principal investigator
RecruitingThomas Jefferson University
Philadelphia, Pennsylvania, United States
- Cecilia Chin, MD · Contact617-835-9038cecillia.chin@jefferson.edu
- Cecilia Chin, MD · Principal investigator
RecruitingAllegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Bart Chess, MD · Contact412-359-8820bart.chess@ahn.org
- Bart Chess, MD · Principal investigator
RecruitingBaylor College of Medicine
Houston, Texas, United States
- Steven Maximus, MD · Contact832-355-9571steven.maximus@bcm.edu
- Steven Maximus, MD · Principal investigator
RecruitingThe Methodist Hospital-Houston
Houston, Texas, United States
- Marvin Atkins, MD · Contact713-441-5200mdatkins@houstonmethodist.org
- Marvin Atkins, MD · Principal investigator
RecruitingBaylor Scott & White Research Institute
Plano, Texas, United States
- Justin Schaffer, MD · Contact469-800-6200justin.schaffer@bswhealth.org
- Justin Schaffer, MD · Principal investigator
RecruitingIntermountain Medical Center
Murray, Utah, United States
- Jane He, MD · Contact801-507-4700jane.he@imail2.org
- Jane He, MD · Principal investigator
RecruitingUniversity of Washington Medical Center
Seattle, Washington, United States
- Matthew Sweet, MD · Contact206-598-8487mpsweet@uw.edu
- Matthew Sweet, MD · Principal investigator
RecruitingUniversity of Wisconsin - Madison
Madison, Wisconsin, United States
- Kyla Bennett, MD · Contact608-265-4420bennettk@surgery.wisc.edu
- Kyla Bennett, MD · Principal investigator
RecruitingMedical College of Wisconsin
Milwaukee, Wisconsin, United States
- Peter Rossi, MD · Contact414-955-1800prossi@mcw.edu
- Peter Rossi, MD · Principal investigator
Recruiting
Study team
Sponsor
W.L.Gore & Associates
Study ID TBE 25-03
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.